Study Conduct

Report: Patients want biosimilars and biologics testing consistency

Friday, June 30, 2017

Health Stories Project—Insights, a new healthcare market intelligence company dedicated to magnifying the patient voice to influence decision making and support movement toward patient-centricity, has announced the launch of its Insights Reports with the publication of a report titled “Biosimilars: Patient Understanding and Attitudes.” The research showed that 81% of patients believe biosimilars and biologics should require the same type and level of testing, and the response is even higher among women (83%) and consumers 55 and older (92%). Among patients not using biologics, more than half said they were interested in learning more about biosimilars.

[Read More]

Roche acquires mySugr to form digital diabetes management open platform

Friday, June 30, 2017

Roche and mySugr announced that the two partners have signed an agreement under which Roche acquired all shares of mySugr. Counting more than one million users globally, mySugr is one of the leading mobile diabetes platforms in the market and will become an integral part of Roche’s new patient-centered digital health services platform in diabetes care. The acquisition allows Roche to expand its leading position in the area of diabetes management.

[Read More]

Median Technologies, Medidata partner on image management services

Tuesday, June 27, 2017

Medidata, a global provider of cloud-based solutions and data analytics for clinical research, and Median Technologies, the Imaging Phenomics Company, announced a new collaboration to streamline the growth and use of medical imaging in cancer clinical trials. Median Technologies will leverage the Medidata Clinical Cloud to accelerate the development of medicines in oncology with new, scalable image management services.

[Read More]

Baheal Group will bring IBM’s Watson for genomics to China

Monday, June 26, 2017

IBM Watson Health announced that Baheal Pharmaceutical Group will bring Watson for Genomics to clinicians across China. As IBM’s primary channel partner for Watson for Genomics in China, Baheal will establish an ecosystem within China to sell the molecular data interpretation technology to clinicians and researchers across the country. The new multi-year agreement comes less than three months after Baheal and IBM launched a strategic alliance to distribute Watson for Oncology in China.

[Read More]

Survey: Sponsors and CROs rely on analytics but are limited to traditional and in-house data

Monday, June 26, 2017

Medidata, a global provider of cloud-based technology and data analytics for clinical research, announced results of an industry survey to better understand how global life sciences companies think about and use data in clinical research. Conducted in partnership with PharmaVOICE magazine and titled “Using Data and Analytics in Clinical Development,” the survey revealed that 90% of respondents rely on some form of analytics solution—viewing data as a critical element for achieving their R&D priorities—but are limited to their own data to make strategic decisions.

[Read More]

Survey: Clinical trials changing dramatically

Friday, June 23, 2017

SCORR Marketing, a global health science marketing and communications firm, has announced that a new survey report, Clinical Trials: Past, Present and Future, is now available for free download. The report, produced in partnership with Applied Clinical Trials, describes what clinical trial professionals perceive to be the biggest changes in clinical trials in the last 10 years and what they expect as they continue to evolve in the future.

[Read More]

Cerner’s Population Health Management Platform chosen by Cerner to coordinate and manage care

Wednesday, June 21, 2017

Cerner, a global leader in health care technology, has announced Carolinas HealthCare System (CHS) has chosen Cerner’s HealtheIntentSM population health management platform to coordinate and manage care for its more than 12 million patient interactions each year across its facilities and clinically integrated network, Carolinas Physician Alliance (CPA). CHS will continue to use the Cerner Millennium® integrated electronic health record (EHR) and will also extend its remote hosting relationship with Cerner.

[Read More]